ArticleNature cancer2022

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia.

Kevin H Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.